Kees Been is the founder of Kynexis. Kynexis has raised $61M in total funding. Latest round: Series A. Based in Cambridge, MA.
Kees Been is the founder and leader of Kynexis, a biotechnology company focused on precision therapeutics for brain diseases. The company launched with €57 million ($61 million) in Series A financing, and Been recently announced the dosing of the first healthy volunteers in their Phase 1 study for KYN-5356.
Full founder directory · Investor directory · Company funding database · Fundraising library